Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruirui Jing

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Medicine|June 4, 2021
Effects of music therapy on cancer-related fatigue, anxiety, and depression in patients with digestive tumors: A protocol for systematic review and meta-analysisXiaxia Chen, Qiuya Wei, Ruirui Jing, et al.
Sheng Wu Gong Cheng Xue Bao = Chinese Journal of Biotechnology|December 28, 2019
[Cell therapy's poster child: Chimeric antigen receptor T cell therapy]Liling Qian, Jiangqing Chen, Xiaoyan Wu, et al.
The Review of Scientific Instruments|October 1, 2022
An improved compressed sensing method for dynamic impact signals based on cubic spline interpolationFujing Xu, Yuting Wang, Tingwei Jia, et al.
Frontiers in Immunology|July 9, 2020
Engineering Cytoplasmic Signaling of CD28ζ CARs for Improved Therapeutic FunctionsXianhui Meng, Ruirui Jing, Liling Qian, et al.
Biomarker Research|July 22, 2024
Correction: CRISPR/Cas-based CAR-T cells: production and applicationPing Song, Qiqi Zhang, Zhiyong Xu, et al.
Biomarker Research|May 30, 2024
CRISPR/Cas-based CAR-T cells: production and applicationPing Song, Qiqi Zhang, Zhiyong Xu, et al.
Frontiers in Immunology|July 8, 2026
Next-generation CAR-T engineering for colorectal cancer: integrating targets, tumor microenvironment barriers, and emerging strategiesYajuan Yang, Zongyue Gao, Ping Song, et al.
Journal of Zhejiang University. Science. B|October 13, 2022
Secondary donor-derived CD19 CAR-T therapy is safe and efficacious in acute lymphoblastic leukemia with extramedullary relapse after first autologous CAR-T therapyDelin Kong, Tingting Yang, Jia Geng, et al.
Current Treatment Options in Oncology|June 22, 2026
Recent Advances in Neoadjuvant Treatment of Anaplastic Thyroid Carcinoma: A Narrative ReviewJuncong Fan, Yeqin Ni, Rong Ni, et al.
Seminars in Immunology|December 4, 2020
Exploiting Ca<sup>2+</sup> signaling in T cells to advance cancer immunotherapyXianhui Meng, Xiaoyan Wu, Yuyuan Zheng, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Medicine|June 4, 2021
Effects of music therapy on cancer-related fatigue, anxiety, and depression in patients with digestive tumors: A protocol for systematic review and meta-analysisXiaxia Chen, Qiuya Wei, Ruirui Jing, et al.
Sheng Wu Gong Cheng Xue Bao = Chinese Journal of Biotechnology|December 28, 2019
[Cell therapy's poster child: Chimeric antigen receptor T cell therapy]Liling Qian, Jiangqing Chen, Xiaoyan Wu, et al.
The Review of Scientific Instruments|October 1, 2022
An improved compressed sensing method for dynamic impact signals based on cubic spline interpolationFujing Xu, Yuting Wang, Tingwei Jia, et al.
Frontiers in Immunology|July 9, 2020
Engineering Cytoplasmic Signaling of CD28ζ CARs for Improved Therapeutic FunctionsXianhui Meng, Ruirui Jing, Liling Qian, et al.
Biomarker Research|July 22, 2024
Correction: CRISPR/Cas-based CAR-T cells: production and applicationPing Song, Qiqi Zhang, Zhiyong Xu, et al.
Biomarker Research|May 30, 2024
CRISPR/Cas-based CAR-T cells: production and applicationPing Song, Qiqi Zhang, Zhiyong Xu, et al.
Frontiers in Immunology|July 8, 2026
Next-generation CAR-T engineering for colorectal cancer: integrating targets, tumor microenvironment barriers, and emerging strategiesYajuan Yang, Zongyue Gao, Ping Song, et al.
Journal of Zhejiang University. Science. B|October 13, 2022
Secondary donor-derived CD19 CAR-T therapy is safe and efficacious in acute lymphoblastic leukemia with extramedullary relapse after first autologous CAR-T therapyDelin Kong, Tingting Yang, Jia Geng, et al.
Current Treatment Options in Oncology|June 22, 2026
Recent Advances in Neoadjuvant Treatment of Anaplastic Thyroid Carcinoma: A Narrative ReviewJuncong Fan, Yeqin Ni, Rong Ni, et al.
Seminars in Immunology|December 4, 2020
Exploiting Ca<sup>2+</sup> signaling in T cells to advance cancer immunotherapyXianhui Meng, Xiaoyan Wu, Yuyuan Zheng, et al.
Pageof 3